Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
13.24
-0.02 (-0.15%)
At close: Mar 6, 2026, 4:00 PM EST
13.15
-0.09 (-0.68%)
After-hours: Mar 6, 2026, 7:30 PM EST
Amneal Pharmaceuticals Employees
Amneal Pharmaceuticals had 8,700 employees as of December 31, 2025. The number of employees increased by 400 or 4.82% compared to the previous year.
Employees
8,700
Change (1Y)
400
Growth (1Y)
4.82%
Revenue / Employee
$346,984
Profits / Employee
$8,282
Market Cap
4.17B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,300 |
| Phibro Animal Health | 2,475 |
| Hims & Hers Health | 2,442 |
| Alkermes | 2,050 |
| HUTCHMED (China) | 1,780 |
| Lantheus Holdings | 1,193 |
| Supernus Pharmaceuticals | 778 |
| Prestige Consumer Healthcare | 600 |
AMRX News
- 1 day ago - Amneal to Participate in Upcoming Investor Conference - GlobeNewsWire
- 8 days ago - Amneal Pharmaceuticals, Inc. (AMRX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Amneal Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - Amneal Pharmaceuticals Added to S&P SmallCap 600® Index - GlobeNewsWire
- 5 weeks ago - TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Healthcare REIT Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600 - PRNewsWire
- 5 weeks ago - Amneal to Report Fourth Quarter and Full Year 2025 Results on February 27, 2026 - GlobeNewsWire
- 7 weeks ago - Amneal Pharmaceuticals, Inc. (AMRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - KeifeRx Announces Research Collaboration and Option Agreement with Amneal Pharmaceuticals to Advance KFRX06, a Brain-Penetrant LRRK2 Program for Parkinson's Disease - Business Wire